Who is sponsoring NCT07340671?

NCT07340671 is sponsored by University of Miami.

What drugs are being tested in NCT07340671?

Interventions in NCT07340671: Cutera® 1726 nm laser system.

What condition does NCT07340671 study?

NCT07340671 studies Frontal Fibrosing Alopecia.

Is NCT07340671 still recruiting?

NCT07340671 is currently not yet recruiting. Last updated 14 January 2026.

Last reviewed 2026-01-14 · How we verify

NCT07340671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Facial Papules in Frontal Fibrosing Alopecia (FFA)

Not yet recruiting NA Last updated 14 January 2026

What this trial tests

NA trial testing Cutera® 1726 nm laser system in Frontal Fibrosing Alopecia in 10 participants. Not yet recruiting.

Timeline

1 February 2026

Primary endpoint
1 December 2028

1 December 2028

Quick facts

Lead sponsor	University of Miami
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	1 February 2026
Primary completion	1 December 2028
Estimated completion	1 December 2028
Sites	1 location across United States

Drugs / interventions tested

Cutera® 1726 nm laser system

Conditions studied

Frontal Fibrosing Alopecia — all drugs for Frontal Fibrosing Alopecia →

Sponsor

University of Miami

Who can join

18 and older, any sex, with Frontal Fibrosing Alopecia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective is to evaluate the safety and efficacy of the Cutera 1726 nm laser system (also referred to as AviClear) for the treatment of facial papules in frontal fibrosing alopecia (FFA).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frontal Fibrosing Alopecia

Currently open trials in the same condition.

NCT06240351 — A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA) · Phase 4 · active not recruiting

Other University of Miami trials

Trials by the same sponsor.

NCT06003712 — Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI) · NA · not yet recruiting
NCT06077071 — MRIdian "RADAR" Trial · NA · not yet recruiting
NCT07472413 — Alternate Pre-med in Anti-Cluster of Differentiation 20 (CD20) Pilot Project · Phase 3 · not yet recruiting
NCT07322289 — Antibiotic-coated Braided Suture Study · NA · not yet recruiting
NCT07469592 — eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07340671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Miami
Last refreshed: 14 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07340671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing